The adrenal medulla of several species and some human pheochromocytomas contain CRH. The first aim of the present work was to find out whether normal rat adrenal chromaffin cells and the PC12 rat pheochromocytoma cell line produce CRH in vitro and what regulates its production. CRH was measured and characterized in the media of both types of chromaffin cells under basal conditions and after exposure to K ϩ , nicotine, interleukin-1␤, and nerve growth factor (NGF). The second aim was to examine the biological effect of exogenous CRH (and of its antagonist) on the production of catecholamines from these two types of cells. Our results are as follows: 1) Both types of chromaffin cells contained and secreted comparable amounts of immunoreactive-CRH under basal conditions and after K ϩ -induced depolarization, nicotine, and interleukin-1␤; 2) the physicochemical characteristics of the immunoreactive-CRH in the cells and the media were identical to the putative CRH peptide on both sieve chromatography and RP-HPLC; 3) synthetic CRH induced the production of catecholamines from both cell types in a dose-and time-dependent manner; this effect was abolished by the antagonist, ␣ helical CRH; 4) exposure of PC12 cells to NGF (for 1 week) resulted in their neuronal differentiation and the stimulation of their production of CRH by 30 times and of dopamine by 10 times, compared with parallel controls; this effect of NGF was abolished by ␣ helical CRH.
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In conclusion, our data suggest that the production of CRH by PC12 cells represents the preservation of a normal chromaffin cell characteristic rather than a tumor-induced ectopic phenomenon. (Endocrinology 138: 698 -704, 1997) C RH IS produced at several extrahypothalamic sites. CRH is detectable in the adrenals of a number of species, including humans (1-4), rodents (5) (6) (7) (8) , cows (9 -11) , and dogs (12) . In dogs, the CRH-producing cells in the adrenals are almost exclusively localized at the outer medullary zone (12) . The physiological role of this CRH is unknown. It has been suggested that adrenal CRH may play a systemic role because stimulation of the adrenal splanchnic nerves creates an immunoreactive (IR)-CRH gradient between adrenal vein and periphery (10) . However, its low concentration and the presence of the CRH-binding protein should minimize any potential systemic effect. It is much more probable that adrenal CRH acts locally, either on the cortex or the medulla, because specific CRH-binding sites are present in primate (13, 14) and rat adrenals (15) . The CRH transcript and IR-CRH have been detected also in some human pheochromocytomas, tumors of adrenal chromaffin cells (2, 3, 16 -19) .
In a pilot experiment, we have found that CRH is present in normal rat adrenal chromaffin cells and in the PC12 rat pheochromocytoma cell line, a model for the study of chromaffin cell differentiation and catecholamine production by pheochromocytomas (20, 21) . The aim of the present work was to test the hypothesis that the production of CRH by PC12 cells represents the preservation of a normal chromaffin cell characteristic and not a tumor-induced expression of a previously unexpressed gene. To prove this hypothesis, we compared dispersed and cultured normal rat chromaffin cells with PC12 cells in relation to CRH secretion, regulation of its production, and response to exogenous CRH and its antagonist. Specifically, we first measured the basal secretion rate of IR-CRH by both types of chromaffin cells and that after exposure to K ϩ , nicotine, interleukin (IL)-1␤ (7, (22) (23) (24) (25) , and nerve growth factor (NGF). Subsequently, we characterized the IR-CRH in these cells and their culture media by sieve chromatography and RP-HPLC. Finally, we examined the effect of exogenous CRH and of its antagonist, ␣ helical CRH (␣hCRH) on basal and nicotine-induced epinephrine secretion from the chromaffin cells and on basal, nicotine-, and NGF-induced dopamine secretion from the PC12 cells. Our results show that CRH is released by both types of cells, its secretion and synthesis seem to be similarly regulated, and it exerts a significant and comparable regulatory effect on the production of catecholamines by both types of chromaffin cells.
Materials and Methods

Culture of normal rat adrenal chromaffin cells
Rat adrenal chromaffin cells were isolated according to a modification of a previously published method (26) . Briefly, adrenal glands obtained from female Sprague-Dawley rats (Charles-Rivers, Milano, Italy) weighing 100 -150 g, were removed immediately after death and placed on sterile petri dishes containing HBSS buffer, 50 IU/ml penicillin G, 50 IU/ml streptomycin (GIBCO-BRL Co., Breda, The Netherlands) The surrounding capsular tissue and fat were removed, each adrenal cut in half, the medullary part dissected out, and the medullae were washed in medium, minced gently to smaller fragments, and placed in the dispersion medium containing HBSS buffer, 50 IU/ml penicillin, 50 IU/ml streptomycin, 0.15% collagenase II, 0.125% trypsin, and 2 U/ml DNase I. After a 90-min incubation at 37 C in a shaker, the process was terminated by the addition of FCS. The medium was centrifuged at 500 ϫ g for 10 min. The cells were resuspended in medium containing DMEM/ HAM's F-12 medium, 15 mm HEPES, 10% FCS, 10 mm glutamine, and antibiotics. Cell suspensions at a concentration of 2-3 ϫ 10 5 cells/ml were layered in transwell plates (Costar Europe LTD, Badhoevedorp, The Netherlands) and left to grow at 5% CO 2 incubator, 37 C (Forma Scientific, Marietta, OH).
Culture of PC12 rat pheochromocytoma cells
The PC12 cells were kindly provided by Dr. G. Guroff, Section on Growth Factors, NICHD, NIH, Bethesda, MD, handled as previously described (21) . Briefly, PC12 cells were cultured on either flat-bottom wells in 12-well plates of 4.5 cm 2 surface area per well (Costar Europe LTD) or on flasks of 75 cm 2 surface area at an initial concentration of 1 ϫ 10 5 cells per cm 2 . The cells were left to grow in DMEM (GIBCO-BRL Co.), containing 10 mm L-glutamine, 1.5 mm HEPES, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 7.5% horse serum, and 7.5% FCS in an incubator (Forma Scientific) at 5% CO 2 and 37 C. Differentiation of PC12 to neuronlike cells followed exposure to 7S NGF (25 ng/ml for 1 week). The 7S NGF was kindly provided by Dr. G. Guroff, Section on Growth Factors, NICHD, NIH, Bethesda, MD.
CRH RIA
Peptides in culture media were concentrated by a C-18 reverse phase column (Sep-Pak, Waters Associates, Milford, MA) after acidification in 2 vol 0.1 N HCI and centrifuged at 1.5 ϫ 10 3 rpm for 10 min. The supernatants were extracted by activated Sep-Pak cartridges, washed with 20 ml 0.1 N HCI eluted with 3 ml acetonitrile 80%-0.01% HCI, then dried under vacuum (Speed-Vac). The IR-CRH content of the Sep-Pak extracts was assayed by RIA using a rabbit antiserum (Neosystem Labboratoire, Strasbourg, France) raised against human/rat CRH; it does not cross-react with ovine CRH, human ACTH, LHRH, or AVP. The sensitivity of the assay was 1 pg/tube. The intraassay coefficient of variation was 4.4% and the interassay was 6.6%. Results are expressed as picograms of IR-CRH per mg of total cellular protein determined on whole cellular homogenates by the Bradford method (27) using BSA as standard (28) .
Sieve chromatography
Pooled culture media and PC12 cell homogenates were acidified in 2 vol 0.1 N HCI, centrifuged at 1 ϫ 10 5 rpm ϫ 10 min and the supernatant extracted by activated Sep-Pak cartridges, washed with 20 ml 0.1 N HCI, eluted with 3 ml acetonitrile 80%-0.01% HCI, and dried under vacuum (Speed-Vac). The sample was reconstituted in 0.5 ml 10% formic acid containing 0.5% defatted BSA and 6 m urea and chromatographed on Sephadex G-50 (0.9 ϫ 60 cm, bed vol 40 ml, flow rate of 1.5 ml/h, 1-ml fractions collected). Fractions were dried under vacuum and reconstituted for RIA. The G-50 column was calibrated with blue dextran and synthetic human CRH. vacuum, reconstituted in 30 l 25% acetonitrile-0.1% TFA, centrifuged again for 10 min and one third of its supernatant was injected into an HPLC connected to a 0.2 ϫ 30 cm C 18 Bondapack column (Waters Associates). A linear gradient program was used, employing a TFAacetonitrile solvent system (see Fig. 3 ). Solvent A was composed of 20% acetonitrile-0.1% TFA and solvent B of 80% acetonitrile-0.1% TFA. The flow rate was 1 ml/min. Samples of 1 ml were collected. The retention time (R t ) of the IR-CRH extracted from the PC12 cells was determined by RIA after evaporation of the HPLC fractions and reconstitution in RIA medium. After the sample runs, 20 ng diluted synthetic r-CRH and a completely oxidized r-CRH by 5% H 2 O 2 were run and their R t determined also by RIA.
RP-HPLC
Measurement of catecholamines
The concentration of the endogenous catecholamines in the culture media was measured as previously described (21) . Briefly, samples of 600 L were aspirated from each well and transferred to tubes containing 100 L 0.1 N HCl to ensure the stability of the catecholamines (stable in acidic pH). Subsequently, catecholamines were extracted by acetone precipitation. The extracts were then evaporated and reconstituted in 200 L of the mobile phase of the HPLC. Samples of 25 L (i.e. one eighth of the initially extracted material) were injected into the RP-HPLC (HP-1090, Hewlett-Packard, Germany) equipped with an electrochemical S100A detector (ESA Inc., Coulochem). The detector was set at ϩ0.45 mV (with respect to an H 2 /H ϩ couple reference electrode) and the guard cell at ϩ0.5 mV. The guard and main columns were RP-18, 5-m particle size (Hewlett-Packard). The size of the main column was 200 ϫ 4.6 mm. The mobile phase was composed of 25 mm NaH 2 PO 4 .H 2 O, 3.2 mm 1-heptane sulfonic acid sodium salt, 0.5 mm EDTA, and 7.5% methanol. The signals were recorded in an analogue digital converter (HP-35900 C, HewlettPackard) connected to an HP-1040 computer.
Statistical analysis
The concentration of the IR-CRH in the culture media was normalized per total cellular protein of the resuspended and homogenized cells at the end of each experiment. The secretion of epinephrine and dopamine in the culture media was expressed as either the mean in ng Ϯ sem of five or more experiments, per well per mg of cell protein or as percent change compared with control wells. Total cellular protein in each well was measured by the Bradford Coomassie Brilliant Blue G250 method (Serva, GmbH & Co, Germany) using BSA as standard (27, 28) . For the statistical evaluation of our data, we used ANOVA followed by two multiple comparison tests: the Fisher's least significant difference and the Newman-Keuls test. For the data expressed as percentages of change over controls, we have used the nonparametric Kruskal-Wallis test for several independent samples.
Results
IR-CRH was detectable in the media and cellular extracts of both normal rat adrenal chromaffin and of the PC12 rat pheochromocytoma cells. Figure 1 depicts the basal concentration of IR-CRH in the culture media over a period of 48 h. The determination of IR-CRH was performed in plain test media after removal of the horse and FCS-enriched culture media. The concentration of IR-CRH in the media from early passage PC12 cells (5 and 6) (lower curve) was lower compared with normal chromaffin cells (upper curve). However, it increased with the number of passage becoming, in late passages, higher than that of chromaffin cells. Thus, PC12 cells of passage 17 had two to three times more CRH compared with normal chromaffin cells (see Fig. 5 ), an observation reproduced in multiple experiments. The significance of the positive correlation between PC12 passage and their capacity to produce CRH is unclear, but it may suggest that the capacity to produce CRH is affected by the state of PC12 differentiation, a hypothesis also supported by the NGFderived data (see below). Figure 1 also shows that replacement of the culture media stimulates the secretion of CRH, which peaks between 6 and 12 h and subsequently either (a) declines slightly reaching a stable plateaux (in the normal chromaffin cells), or (b) it declines even further to low levels (in the PC12 cells). The latter is a well-documented phenomenon, characteristic of several neoplastic cells, including pheochromocytomas; it results from the production of large quantities of proteases from the tumoral cells (29) . Incubation of similar concentrations of standard CRH in PC12-conditioned media produced a similar curve. Based on these data, for the subsequent experiments testing the effect of exogenous CRH, we used aprotinin at 100 kU/ml to protect it from these proteases. Figure 2 depicts the effect of a depolarizing dose of KCl on IR-CRH in the PC12 test media (n ϭ 6). The peak CRH response occurred at 20 min, and it was almost one order of magnitude higher than that of parallel controls (from 18.6 Ϯ 3 to 138 Ϯ 1, n ϭ 12). Similar data were obtained from normal rat chromaffin cells. On sieve chromatography, the apparent molecular weight of IR-CRH in the test media was similar or identical to that of synthetic r-CRH (Fig. 2, insert) . Figure 3 depicts the RP-HPLC chromatographic profile of IR-CRH present in PC12 cellular extracts. A gradient of acetonitrile (CH 3 CN) was used (indicated by the broken line) in the presence of 0.1 N TNF. The R t of IR-CRH from the PC12 extracts was identical to that of synthetic r-CRH. On the graph, the first peak represents the oxidized Met(O) CRH (this oxidation takes place during the extraction procedure), whereas the second peak is that of the putative peptide. RP-HPLC chromatography of pooled extracts from 24-h PC12 culture media exhibited the same IR-CRH profile. Figure 4 depicts the effect of nicotine on the release of IR-CRH from normal chromaffin (upper panel) and PC12 cells (lower panel). Nicotine stimulated the release of IR-CRH from both types of cells in a dose-and time-dependent manner. The onset of this effect was early, starting within 30 min of the application of nicotine. This finding suggests that, as expected, the stimulatory effect of nicotine mainly involves secretion.
It is now known that IL-1␤ stimulates the synthesis of CRH in the parvo cells of the paraventricular hypothalamic nucleus (30) . Figure 5 depicts the effect of IL-1␤, at 40 ng/ml for 36 h, on the rate of IR-CRH accumulation in the test media of normal chromaffin cells (light grey bars) and of PC12 cells (white bars). The onset of the effect of IL-1␤ required at least 36 h of exposure, suggesting that it involved mainly synthesis. Indeed, IL-1␤ had no statistically significant acute effects on CRH secretion from either type of chromaffin cell. It should be noted that the one order of magnitude difference between the basal (zero exogenous IL-1␤) concentration of IR-CRH in this experiment (PC12 passage 17) compared with the one depicted in Fig. 1 (PC12 passage 6) illustrates the significance of the number of passage on CRH production.
As expected, exposure of PC12 to 7S NGF (25 ng/ml for 1 week) induced their differentiation to neuron-like cells. The thus differentiated PC12 cells exhibited a highly significant increase in their capacity to produce CRH (as well as catecholamines). phenomenon described previously for normal chromaffin cells (13) . Thus, the data for the dose response curves were taken from cultures exposed to CRH for 12 h. To protect synthetic CRH from tumor-derived proteases, aprotinin (100 kU/ml) was used. This concentration of aprotinin was sufficient to prevent CRH degradation. Differentiation of PC12 to neuron-like cells after exposure to 7S NGF (25 ng/ml for 1 week) resulted in an increase of their production of dopamine. Figure 9 depicts the accumulation of dopamine into the culture media of the neuronally differentiated cells over 12 h. The differentiated cells produced almost 10 times more dopamine compared with PC12 cells exposed only to the NGF vehicle (control cells). The increased rate of dopamine accumulation in the NGF-treated cells was prevented completely by preincubation with the CRH antagonist ahCRH at 10 Ϫ6 m, suggesting that endogenous CRH may mediate this phenomenon. Synthetic CRH did not affect the production of catecholamines from NGFdifferentiated PC12 cells, suggesting that the local CRH receptors were already downregulated.
Discussion
Our results indicate that the CRH neuropeptide is produced by both normal rat adrenal chromaffin cells and the widely used PC12 rat pheochromocytoma cell line. Our data supplement previously published results in other species (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . It now seems that the capacity to produce CRH is a property of normal adrenal chromaffin cells and that the production of CRH by the PC12 cells may represent the preservation of a normal chromaffin cell characteristic rather than a tumor-induced ectopic phenomenon. This hypothesis may be applicable also to human pheochromocytomas. Indeed, our data show that the amount of CRH produced by the normal rat chromaffin cells and the tumoral PC12 cells and their responce to a variety of stimuli was similar or identical, suggesting that the pathway of CRH synthesis remains intact in the PC12 cells.
The release of IR-CRH into the culture media paralleled that of catecholamines, suggesting costorage, a property characteristic of most neural crest-derived cells in which neuropeptides and neurotransmitters are packaged into the same secretory granules (31) . The role of adrenomedullary CRH and the physiological significance of its simultaneous release with catecholamines is not known.
IL-1␤ stimulates the production of CRH from the parvo cells of the paraventricular hypothalamic nucleus (30) . We have found that normal chromaffin cells and the PC12 cell line responded to IL-1␤ by an increase of CRH release of late onset, suggesting that, in similarity to hypothalamus, this cytokine affects CRH synthesis rather than secretion.
The concentration of CRH in the normal chromaffin and the PC12 media was in the range of 0.2-0.5 ϫ 10 Ϫ11 m. This secretion rate suggests that chromaffin cell-derived CRH can not have systemic effects. It is more likely that its effects are confined within the adrenals. Indeed, the calculated in vivo concentration of CRH in the interstitial compartment of an intact adrenal medulla may reach the biologically active levels of 1-2 ϫ 10 Ϫ10 m, i.e. near the Kd of the CRH receptor. In the central nervous system, there is a close anatomical proximity between CRH and noradrenergic neurons at the level of locus ceruleus (32, 33) . In the rat, CRH stimulates the release of catecholamines from locus ceruleus, as well as from hypothalamus, medial prefrontal cortex, and the hippocampal dentate gyrus in vivo (34 -37) . This effect of CRH is blocked by ␣hCRH (37). This effect of CRH involves catecholamine synthesis via stimulation of the activity of tyrosine hydroxylase, the rate limiting enzyme (38, 39) . All available evidence indicates that CRH plays a similar role in the adrenal medulla because the latter also contains CRH receptors (13, 14) . Our data support this hypothesis, demonstrating a dose-depended stimulatory effect of CRH on the production of catecholamines from both normal and PC12 tumoral rat adrenal chromaffin cells. The apparent preservation, by PC12 cells, of the CRH-mediated effect on catecholamine synthesis may suggest that CRH is an important component of the adrenomedullary physiology.
A well-documented characteristic of the PC12 line is its differentiation to neuron-like cells after exposure to NGF for 1 week. We have found that the neuron-like PC12 cells secreted 10 times more catecholamines compared with parallel controls and thirty times more CRH. Our finding is in complete agreement with previously published data from primary cultures of human pheochromocytomas, in which NGF increased the concentration of CRH mRNA by 10-fold (19) . The stimulatory effect of NGF on the capacity of PC12 cells to produce catecholamines seems to involve CRH because exposure of PC12 cells to the CRH antagonist, ahCRH, during the incubation with NGF completely abolished the NGFmediated stimulatory effect. It is thus possible that the following sequence of events takes place: the NGF-induced differentiation of PC12 cells causes an increase in their CRHproducing capacity; the high levels of PC12-derived CRH act in a paracrine manner and stimulate the synthesis of tyrosine hydroxylase, which stimulates the synthesis of catecholamines. Blockage of the endogenous CRH paracrine effect prevents the stimulatory effect of NGF.
Exogenous synthetic CRH did not affect the production of catecholamines from the NGF-differentiated PC12 cells, in contrast to the NGF-unexposed PC12 cells. This finding suggests that either the PC12 CRH receptors were already maximally activated and possibly downregulated or the production of catecholamines was already at its highest possible level as a consequence of the NGF-induced differentiation.
In conclusion, our data suggest that the production of CRH by PC12 cells represents the preservation of a normal chromaffin cell characteristic rather than a tumor-induced ectopic phenomenon. From a clinical point of view, our findings may be of value in some inoperable pheochromocytomas in which the production of catecholamines could be inhibited by the new nonpeptide CRH antagonists.
